Mono Pharmacare Limited
ListedSMEHealthcare · NSE
Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.
Price Band
₹26 – ₹28
Issue Size
₹14.84 Cr
Lot Size
4000 shares
GMP
₹2
+7.1%
Est. Listing
₹30
at current GMP
Subscribed
13.47x
overall
Open
28 Aug 2023
Close
30 Aug 2023
Allotment
4 Sep 2023
Refund
5 Sep 2023
Demat Credit
6 Sep 2023
Listing
7 Sep 2023
Last updated 12 days ago
Overall Subscription
13.47x
Total Demand
QIB Multiplier
10.89x
Institutions & Funds
NII / HNI
8.12x
High Net-Worth
Retail (RII)
19.39x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 500,000 | 5,444,000 | 10.89x |
| NIB | 2,260,000 | 18,348,000 | 8.12x |
| RETAIL | 2,264,000 | 43,888,000 | 19.39x |
| Total | 5,024,000 | 67,680,000 | 13.47x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 464 | 8,997 | 19.39x |
| HNIs (10L +) | 3 | 24 | 8.12x |
| HNIs (2-10L) | 14 | 114 | 8.12x |
| Total Applications | 481 | 9,135 | 18.99x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Mono Pharmacare Limited Public Issue & Market Profile
Mono Pharmacare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹14.84 Crores. The shares are offered at a price band of ₹26 to ₹28 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2023-08-30, the basis of allotment is scheduled to be finalized on 2023-09-04. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Mono Pharmacare Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Mono Pharmacare Limited IPO is ₹2 per equity share. Based on the upper price band of ₹26 to ₹28 per equity share, the estimated listing price is ₹30 (+7.1% expected listing gain).
What is the expected profit per lot for Mono Pharmacare Limited IPO?
With a lot size of 4000 shares and current GMP of ₹2, the expected profit per application lot is approx ₹8,000 (+7.1% gain). Minimum application cost is approx ₹1,12,000.
What is the issue size and price band for Mono Pharmacare Limited IPO?
The Mono Pharmacare Limited IPO aggregate issue size is ₹14.84 Crores with an equity price band set at ₹26 to ₹28 per equity share. The retail lot size is 4000 shares requiring a minimum capital outlay of approx. ₹1,12,000.
How can I check Mono Pharmacare Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 13.47x (Retail: 19.39x, QIB: 10.89x, NII: 8.12x). You can track live multiples directly on our dedicated subscription page.
Where and when will Mono Pharmacare Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2023-09-04. Investors can verify status using PAN card or application number.
When is the listing date for Mono Pharmacare Limited IPO?
Mono Pharmacare Limited shares are scheduled to list on NSE on 2023-09-07.